Andere Kunden interessierten sich auch für
![Methodological Challenges in Biomedical HIV Prevention Trials]( "Methodological Challenges in Biomedical HIV Prevention Trials")
Methodological Challenges in Biomedical HIV Prevention Trials74,99 €![HIV Screening and Access to Care]( "HIV Screening and Access to Care")
HIV Screening and Access to Care34,99 €![Monitoring HIV Care in the United States]( "Monitoring HIV Care in the United States")
Monitoring HIV Care in the United States51,99 €![HIV Screening and Access to Care]( "HIV Screening and Access to Care")
HIV Screening and Access to Care33,99 €![Monitoring HIV Care in the United States]( "Monitoring HIV Care in the United States")
Monitoring HIV Care in the United States71,99 €![HIV and Disability]( "HIV and Disability")
HIV and Disability54,99 €![Strategic Approach to the Evaluation of Programs Implemented Under the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against Hiv/Aids, Tuberculosis, and Malaria Reauthorization Act of 2008]( "Strategic Approach to the Evaluation of Programs Implemented Under the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against Hiv/Aids, Tuberculosis, and Malaria Reauthorization Act of 2008")
Strategic Approach to the Evaluation of Programs Implemented Under the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against Hiv/Aids, Tuberculosis, and Malaria Reauthorization Act of 200867,99 €
Mother-to-child transmission of HIV-1 afflicts hundreds of thousands of children every year, especially in parts of the world such as sub-Saharan Africa, where HIV infection is prevalent and resources are limited. This tragic reality has spurred researchers to search for an effective, safe, and inexpensive treatment that could reduce the risk of perinatal HIV transmission. The HIVNET 012 trial was designed to provide preliminary information on the comparative safety and efficacy of two relatively simple and inexpensive short courses of oral antiretroviral treatment likely to be feasible in resource-limited settings. The resulting report identified some problems with procedures and documentation, but concluded that these issues did not compromise the results of the study. However, these issues have led to public scrutiny and continued controversy. Review of the HIVNET 012 Perinatal HIV Prevention Study critically and objectively evaluates the study's design and conduct, and assesses the impact of the initial procedural issues on the validity of the overall findings and conclusions of the trial.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.